Myalgic Encephalomyelitis and Chronic Fatigue Syndrome - Background Information for ME and CFS Stakeholder Teleconference

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


Content

No documents available.

Attachments

 (1)

Myalgic Encephalomyelitis and Chronic Fatigue Syndrome Background Information for ME and CFS Stakeholder Teleconference

View Attachment:
Authors: cder
 

 
 
Comment Period Closed
Sep 30 2013, at 11:59 PM ET
ID: FDA-2012-N-0962-0001

Document Information

Date Posted: Sep 12, 2012
Show More Details  

Comments

18
Comments Received*
These comments are sent for the FDA CFS Drug Development Meeting April 25-26, 2013, Pooks Hill Marriot Our data is rapidly being published and I have tried to...
2/24/2013 As you have posted the dates for the ME/CFS FDA Stakeholder meeting, where is the request for patient input re: ME/CFS expert clinicians...
I am an advisor for ME/CFS in the UK we feel that once the USA recognises this as a neurological disease, caused by an infectious agent, our government will...

Docket Information

This document is contained in
Related Dockets:
None
Related RINs: None
Related Comments:

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.